Central Alerting System
View Alert

Originator: National Patient Safety Alert - DHSC

Issue date: 24-May-2023 14:02:25

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Special Health Authorities
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Shortage of pyridostigmine 60mg tablets

Broadcast content:

Pyridostigmine 60mg tablets are out of stock, resupply is expected week commencing 12 June 2023.

There are three suppliers of pyridostigmine 60mg tablets: Viatris, Teva and Flynn Pharma. The supply issue is caused by a combination of manufacturing issues and a resulting increase in demand to other suppliers.  

This National Patient Safety Alert provides further background and clinical information and actions for providers.

Additional information: NHS England Regional Offices: please cascade this alert to community pharmacy contractors

Alert reference: NatPSA/2023/006/DHSC

Action underway deadline: 26-May-2023

Action complete deadline: 26-May-2023


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency